Boxer Capital Management

Boxer Capital Management as of June 30, 2026

Portfolio Holdings for Boxer Capital Management

Boxer Capital Management holds 63 positions in its portfolio as reported in the June 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Tango Therapeutics (TNGX) 25.6 $340M 11M 31.26
Revolution Medicines (RVMD) 7.1 $94M 500k 187.28
Abivax Sa Sponsored Ads (ABVX) 6.1 $81M 605k 133.26
Uniqure Nv SHS (QURE) 5.2 $69M 1.5M 46.06
Kodiak Sciences (KOD) 4.3 $58M 1.5M 38.96
Kymera Therapeutics (KYMR) 3.7 $49M 429k 114.67
Definium Therapeutics Com Shs (DFTX) 3.5 $47M 999k 47.04
Replimune Group (REPL) 3.3 $44M 4.0M 11.07
Celcuity (CELC) 3.3 $44M 417k 104.62
Q32 Bio (QTTB) 3.0 $40M 3.1M 12.74
Capricor Therapeutics Com New (CAPR) 2.5 $34M 1.4M 24.08
Precigen (PGEN) 2.2 $29M 5.2M 5.70
Corcept Therapeutics Incorporated (CORT) 2.2 $29M 336k 86.95
Surrozen Com New (SRZN) 2.0 $27M 1.1M 24.39
Protagonist Therapeutics (PTGX) 1.6 $21M 170k 122.58
Vir Biotechnology (VIR) 1.4 $19M 1.9M 10.19
Vaxcyte (PCVX) 1.4 $19M 325k 58.13
Urogen Pharma (URGN) 1.4 $18M 500k 36.80
Corvus Pharmaceuticals (CRVS) 1.2 $16M 1.1M 14.94
Ptc Therapeutics I (PTCT) 1.2 $16M 200k 81.57
Praxis Precision Medicines I Com New (PRAX) 1.2 $16M 47k 334.79
Amylyx Pharmaceuticals (AMLX) 1.1 $14M 800k 17.96
Ocular Therapeutix (OCUL) 1.0 $13M 1.3M 9.82
Ocuphire Pharma (IRD) 0.9 $12M 2.8M 4.11
Palisade Bio (PALI) 0.8 $10M 4.8M 2.09
Apogee Therapeutics (APGE) 0.7 $9.3M 70k 132.73
Spyre Therapeutics Com New (SYRE) 0.7 $8.9M 100k 88.78
Cogent Biosciences (COGT) 0.7 $8.7M 225k 38.70
Cytokinetics Com New (CYTK) 0.6 $8.5M 100k 85.19
Relay Therapeutics (RLAY) 0.6 $8.4M 450k 18.71
Crescent Biopharma 0.6 $8.2M 454k 18.00
Contineum Therapeutics Cl A (CTNM) 0.6 $8.1M 494k 16.39
Kazia Therapeutics Sponsored Ads (KZIA) 0.6 $7.9M 560k 14.08
Shattuck Labs (STTK) 0.5 $6.9M 1.0M 6.94
Avalo Therapeutics Com New (AVTX) 0.5 $6.9M 375k 18.48
Forte Biosciences Com New (FBRX) 0.4 $5.8M 275k 21.25
Relmada Therapeutics (RLMD) 0.4 $5.8M 842k 6.92
Moonlake Immunotherapeutics Class A Ord (MLTX) 0.4 $5.4M 275k 19.47
Zura Bio Class A Ord Shs (ZURA) 0.4 $5.3M 900k 5.90
Cybin Com New (HELP) 0.4 $5.2M 790k 6.61
Odyssey Therapeutics Common Stock 0.4 $5.1M 275k 18.71
Immatics SHS (IMTX) 0.4 $4.8M 475k 10.13
Faeth Therapeutics Com New (FTH) 0.3 $4.5M 181k 25.00
Structure Therapeutics Sponsored Ads (GPCR) 0.3 $4.0M 75k 53.67
Oric Pharmaceuticals (ORIC) 0.3 $3.8M 350k 10.83
An2 Therapeutics (ANTX) 0.3 $3.6M 749k 4.84
Neumora Therapeutics (NMRA) 0.3 $3.4M 2.0M 1.70
Inovio Pharmaceuticals Com Shs (INO) 0.2 $3.1M 2.8M 1.10
Allogene Therapeutics (ALLO) 0.2 $3.1M 1.5M 2.08
Solid Biosciences Com New (SLDB) 0.2 $3.0M 300k 9.99
Karyopharm Therapeutics Com New (KPTI) 0.2 $3.0M 303k 9.77
Clene Com New (CLNN) 0.2 $2.9M 478k 6.16
Sarepta Therapeutics (SRPT) 0.2 $2.7M 150k 17.97
Maplight Therapeutics (MPLT) 0.2 $2.7M 75k 35.84
Nurix Therapeutics (NRIX) 0.2 $2.4M 100k 24.26
Lb Pharmaceuticals Com Shs (LBRX) 0.2 $2.3M 70k 32.45
Edesa Biotech Com New (EDSA) 0.1 $1.7M 205k 8.13
Adagio Therapeutics (IVVD) 0.1 $1.3M 1.5M 0.87
Upstream Bio (UPB) 0.1 $1.0M 150k 6.92
Milestone Pharmaceuticals (MIST) 0.1 $893k 667k 1.34
Pepgen (PEPG) 0.0 $491k 273k 1.80
Regenxbio Inc equity us cm (RGNX) 0.0 $180k 15k 11.98
Surrozen *w Exp 08/01/203 (SRZNW) 0.0 $1.1k 67k 0.02